Baxter Healthcare Corporation recalls CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations
- Products
-
- CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection
- Where it was sold
-
US Nationwide; Puerto Rico; and Chile.
Nationwide
- Units affected
- N/A
- About this recall
- CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-016-10.